Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada flag Canada · Delayed Price · Currency is CAD
0.5500
0.00 (0.00%)
At close: Mar 20, 2026

TSXV:EBM Cash Flow Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Net Income
-0.33-0.46-0.55-0.15-0.6
Depreciation & Amortization
0.040.110.110.110.11
Other Operating Activities
00.0200-0.01
Change in Accounts Receivable
0.03-0.030-0.010
Change in Accounts Payable
0.01-0.030.040.01-0.01
Change in Unearned Revenue
-0.01-0.060.0500.02
Change in Other Net Operating Assets
0.280.420.330.030.38
Operating Cash Flow
0.02-0.02-0.02-0-0.12
Capital Expenditures
----0-0.01
Investing Cash Flow
----0-0.01
Short-Term Debt Issued
0.020.040.05--
Long-Term Debt Issued
---0.060.02
Total Debt Issued
0.020.040.050.060.02
Short-Term Debt Repaid
-0.02-0.04-0.05--
Long-Term Debt Repaid
----0.03-
Total Debt Repaid
-0.02-0.04-0.05-0.03-
Net Debt Issued (Repaid)
-0-0-00.030.02
Financing Cash Flow
-0-0-00.030.02
Net Cash Flow
0.02-0.02-0.020.02-0.1
Free Cash Flow
0.02-0.02-0.02-0.01-0.12
Free Cash Flow Margin
2.47%-2.17%-1.95%-0.56%-12.41%
Free Cash Flow Per Share
-----0.00
Levered Free Cash Flow
0.180.180.180.020.11
Unlevered Free Cash Flow
0.190.180.190.020.11
Change in Working Capital
0.30.310.420.030.39
Source: S&P Global Market Intelligence. Standard template. Financial Sources.